(Q37760873)

22 August 2017

1 reference

title

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach (English)

1 reference

22 August 2017

0 references

Stefano Del Prato

7

0 references

Juliana Chung-ngor Chan

object named as

Juliana Chan

3

0 references

author name string

Paolo Pozzilli

1

1 reference

22 August 2017

R David Leslie

2

1 reference

22 August 2017

Ralph De Fronzo

4

1 reference

22 August 2017

Louis Monnier

5

1 reference

22 August 2017

Itamar Raz

6

1 reference

22 August 2017

publication date

1 May 2010

1 reference

Diabetes - Metabolism: Research and Reviews

22 August 2017

published in

1 reference

22 August 2017

volume

26

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

239-244

1 reference

Systematic Review: Comparative Effectiveness and Safety of Oral Medications for Type 2 Diabetes Mellitus

22 August 2017

cites work

1 reference

Systematic review: glucose control and cardiovascular disease in type 2 diabetes

21 January 2018

1 reference

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

21 January 2018

1 reference

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

7 January 2021

Megatrials in type 2 diabetes. From excitement to frustration?

1 reference

7 January 2021

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

7 January 2021

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

1 reference

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

7 January 2021

Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

7 January 2021

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

7 January 2021

Oral Antidiabetic Agents

1 reference

7 January 2021

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: a meta-analysis of randomized clinical trials.

1 reference

7 January 2021

Hypoglycaemia in Type 2 diabetes

1 reference

7 January 2021

Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Card

1 reference

7 January 2021

Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes

1 reference

7 January 2021

Clinical application of incretin-based therapy: therapeutic potential, patient selection and clinical use.

1 reference

7 January 2021

Hypoglycemia-associated autonomic failure in advanced type 2 diabetes

1 reference

7 January 2021

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

7 January 2021

Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.1092

1 reference

22 August 2017

1 reference